Showing results (491-500 of 559) with videos related to
Sort By:
Pageof 56
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2002
Mutations associated with base excision repair deficiency and methylation-induced genotoxic stressRobert W Sobol, David E Watson, Jun Nakamura, et al.Transplantation|March 8, 2016
Nox2 and Cyclosporine-Induced Renal HypoxiaArjang Djamali, Nancy A Wilson, Elizabeth A Sadowski, et al.The Journal of Biological Chemistry|November 21, 2002
A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptorJeffrey Thomas, Kelli S Bramlett, Chahrzad Montrose, et al.Journal of Lipid Research|December 8, 2024
Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplinCraig A Swearingen, John H Sloan, Grace M Rhodes, et al.Matrix Biology : Journal of the International Society for Matrix Biology|September 28, 1998
Expression of mRNA for type IV collagen alpha1, alpha5 and alpha6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndromeS Sasaki, B Zhou, W W Fan, et al.Cancer Research|October 19, 2007
MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell linesBing Yang, Sean M O'Herrin, Jianqiang Wu, et al.Thyroid : Official Journal of the American Thyroid Association|May 28, 2013
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancerFrauke Bentzien, Marcus Zuzow, Nathan Heald, et al.Science (New York, N.Y.)|March 29, 2008
Dynamics of Saturn's south polar vortexUlyana A Dyudina, Andrew P Ingersoll, Shawn P Ewald, et al.Journal of Medicinal Chemistry|November 17, 2015
Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of DyslipidemiaMichael J Genin, Ana B Bueno, Javier Agejas Francisco, et al.Cancer Research|October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinasesFawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.Pageof 56